TY - JOUR
T1 - Platelet CD40 exacerbates atherosclerosis by transcellular activation of endothelial cells and leukocytes
AU - Gerdes, Norbert
AU - Seijkens, Tom
AU - Lievens, Dirk
AU - Kuijpers, Marijke J.E.
AU - Winkels, Holger
AU - Projahn, Delia
AU - Hartwig, Helene
AU - Beckers, Linda
AU - Megens, Remco T.A.
AU - Boon, Louis
AU - Noelle, Randolph J.
AU - Soehnlein, Oliver
AU - Heemskerk, Johan W.M.
AU - Weber, Christian
AU - Lutgens, Esther
N1 - Publisher Copyright:
© 2016 American Heart Association, Inc.
PY - 2016/3/1
Y1 - 2016/3/1
N2 - Objective - Beyond their eminent role in hemostasis and thrombosis, platelets are recognized as mediators of inflammation. Platelet cluster of differentiation 40 (CD40) ligand (CD40L and CD154) plays a key role in mediating platelet-induced inflammation in atherosclerosis. CD40, the receptor for CD40L, is present on platelets; however, the role of CD40 on this cell type is until now undefined. Approach and Results - We found that in both mice and humans, platelet CD40 mediates the formation of platelet-leukocyte aggregates and the release of chemokine (C-X-C motif) ligand 4. Leukocytes were also less prone to adhere to CD40-deficient thrombi. However, platelet CD40 was not involved in platelet aggregation. Activated platelets isolated from Cd40-/-Apoe-/- mice adhered less to the endothelium upon injection into Apoe-/- mice when compared with CD40-sufficient platelets. Furthermore, lack of CD40 on injected platelets led to reduced leukocyte recruitment to the carotid artery as assayed by intravital microscopy. This was accompanied by a decrease in endothelial vascular cell adhesion molecule-1, platelet endothelial cell adhesion molecule, VE-cadherin, and P-selectin expression. To investigate the effect of platelet CD40 in atherosclerosis, Apoe-/- mice received thrombin-activated Apoe-/- or Cd40-/-Apoe-/- platelets every 5 days for 12 weeks, starting at the age of 17 weeks, when atherosclerotic plaques had already formed. When compared with mice that received Apoe-/- platelets, those receiving Cd40-/-Apoe-/- platelets exhibited a >2-fold reduction in atherosclerosis. Plaques of mice receiving CD40-deficient platelets were less advanced, contained less macrophages, neutrophils, and collagen, and displayed smaller lipid cores. Conclusions - Platelet CD40 plays a crucial role in inflammation by stimulating leukocyte activation and recruitment and activation of endothelial cells, thereby promoting atherosclerosis.
AB - Objective - Beyond their eminent role in hemostasis and thrombosis, platelets are recognized as mediators of inflammation. Platelet cluster of differentiation 40 (CD40) ligand (CD40L and CD154) plays a key role in mediating platelet-induced inflammation in atherosclerosis. CD40, the receptor for CD40L, is present on platelets; however, the role of CD40 on this cell type is until now undefined. Approach and Results - We found that in both mice and humans, platelet CD40 mediates the formation of platelet-leukocyte aggregates and the release of chemokine (C-X-C motif) ligand 4. Leukocytes were also less prone to adhere to CD40-deficient thrombi. However, platelet CD40 was not involved in platelet aggregation. Activated platelets isolated from Cd40-/-Apoe-/- mice adhered less to the endothelium upon injection into Apoe-/- mice when compared with CD40-sufficient platelets. Furthermore, lack of CD40 on injected platelets led to reduced leukocyte recruitment to the carotid artery as assayed by intravital microscopy. This was accompanied by a decrease in endothelial vascular cell adhesion molecule-1, platelet endothelial cell adhesion molecule, VE-cadherin, and P-selectin expression. To investigate the effect of platelet CD40 in atherosclerosis, Apoe-/- mice received thrombin-activated Apoe-/- or Cd40-/-Apoe-/- platelets every 5 days for 12 weeks, starting at the age of 17 weeks, when atherosclerotic plaques had already formed. When compared with mice that received Apoe-/- platelets, those receiving Cd40-/-Apoe-/- platelets exhibited a >2-fold reduction in atherosclerosis. Plaques of mice receiving CD40-deficient platelets were less advanced, contained less macrophages, neutrophils, and collagen, and displayed smaller lipid cores. Conclusions - Platelet CD40 plays a crucial role in inflammation by stimulating leukocyte activation and recruitment and activation of endothelial cells, thereby promoting atherosclerosis.
KW - CD40 ligand
KW - atherosclerosis
KW - blood platelets
KW - immune system
KW - leukocytes
UR - http://www.scopus.com/inward/record.url?scp=84959453038&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84959453038&partnerID=8YFLogxK
U2 - 10.1161/ATVBAHA.115.307074
DO - 10.1161/ATVBAHA.115.307074
M3 - Article
C2 - 26821950
AN - SCOPUS:84959453038
SN - 1079-5642
VL - 36
SP - 482
EP - 490
JO - Arteriosclerosis, thrombosis, and vascular biology
JF - Arteriosclerosis, thrombosis, and vascular biology
IS - 3
ER -